445306-48-9Relevant academic research and scientific papers
Substituted cycloalkyl P1' hepatitis C virus inhibitors
-
Page/Page column 132, (2010/02/06)
The present invention relates to tripeptide compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. In particular, the present invention provides novel tripeptide analogs, pharmaceutical compositions containing such analogs and methods for using these analogs in the treatment of HCV infection.
HETEROCYCLICSULFONAMIDE HEPATITIS C VIRUS INHIBITORS
-
Page 87, (2010/02/05)
The present invention relates to tripeptide compounds, compositionscontaining such compounds and methods for using such compounds for the treatment of heptitis C virus (HCV) infection. In particular, the present invention provides novel tripeptide analogs, pharmaceutical compositionscontaining such analogs and methods for using these analogs in the treatment of HCV infection.
